ID

17357

Description

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT00325143

Link

https://clinicaltrials.gov/show/NCT00325143

Keywords

Versions (1)
  1. 9/7/16 9/7/16 -
Uploaded on

September 7, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio, Haemophilus Influenzae Type B NCT00325143

English

Eligibility Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio, Haemophilus Influenzae Type B NCT00325143

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects must have been enrolled in the rota-028 study.
Description

Enrollment Clinical Trial Preceding

Data type

boolean

Alias
UMLS CUI [1,1]
C1516879
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C0332152
subjects for whom the investigator believes that their parents/guardians can and will comply with the requirements of the protocol should be enrolled in the study.
Description

Protocol Compliance parent | Protocol Compliance Guardian

Data type

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0030551
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C1274041
a male or female between, and including, 11 and 17 weeks of age at the time of the first vaccination.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent obtained from the parent or guardian of the subject.
Description

Informed Consent parent | Informed Consent Guardian

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0030551
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1274041
free of obvious health problems as established by medical history and clinical examination before entering into the study.
Description

Disease Free of | examination; clinical

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332296
UMLS CUI [2]
C1456356
subjects should have received two doses of hepatitis b vaccine: at birth and at approximately one month of age.
Description

Hepatitis B vaccination Dosage Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0474232
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs during the study period.
Description

Immunosuppressive Agents Administration chronic | Biological Response Modifiers

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0205191
UMLS CUI [2]
C0005525
planned administration/ administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of the vaccine and ending 30 days after.
Description

Vaccine Illicit Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0332266
UMLS CUI [1,3]
C2348563
any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (hiv) infection.
Description

Immunosuppression | Immunologic Deficiency Syndromes | HIV Infections

Data type

boolean

Alias
UMLS CUI [1]
C4048329
UMLS CUI [2]
C0021051
UMLS CUI [3]
C0019693
a family history of congenital or hereditary immunodeficiency.
Description

Immunodeficiency congenital Family history | Immunodeficiency Hereditary Family history

Data type

boolean

Alias
UMLS CUI [1,1]
C0853602
UMLS CUI [1,2]
C0241889
UMLS CUI [2,1]
C0021051
UMLS CUI [2,2]
C0439660
UMLS CUI [2,3]
C0241889
history of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
Description

History of allergies | history of allergic reaction | Exacerbation Probably Due to Vaccine Component

Data type

boolean

Alias
UMLS CUI [1]
C0489531
UMLS CUI [2]
C2106654
UMLS CUI [3,1]
C0235874
UMLS CUI [3,2]
C0750492
UMLS CUI [3,3]
C0678226
UMLS CUI [3,4]
C0042210
UMLS CUI [3,5]
C1705248
major congenital defects or serious chronic illness.
Description

Congenital Abnormality Major | Chronic disease Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0000768
UMLS CUI [1,2]
C0205164
UMLS CUI [2,1]
C0008679
UMLS CUI [2,2]
C0205404
history of any neurologic disorders or seizures.
Description

nervous system disorder | Seizures

Data type

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0036572
acute disease at the time of enrolment.
Description

Acute Disease

Data type

boolean

Alias
UMLS CUI [1]
C0001314
administration of immunoglobulins and/or any blood products since birth or planned administration during the study period.
Description

Immunoglobulins | Blood product | Immunoglobulins Administration Planned | Blood product Administration Planned

Data type

boolean

Alias
UMLS CUI [1]
C0021027
UMLS CUI [2]
C0456388
UMLS CUI [3,1]
C0021027
UMLS CUI [3,2]
C1533734
UMLS CUI [3,3]
C1301732
UMLS CUI [4,1]
C0456388
UMLS CUI [4,2]
C1533734
UMLS CUI [4,3]
C1301732
Back to the top of the page

Similar models

Eligibility Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio, Haemophilus Influenzae Type B NCT00325143

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Enrollment Clinical Trial Preceding
Item
subjects must have been enrolled in the rota-028 study.
boolean
C1516879 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
Protocol Compliance parent | Protocol Compliance Guardian
Item
subjects for whom the investigator believes that their parents/guardians can and will comply with the requirements of the protocol should be enrolled in the study.
boolean
C0525058 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C1274041 (UMLS CUI [2,2])
Age
Item
a male or female between, and including, 11 and 17 weeks of age at the time of the first vaccination.
boolean
C0001779 (UMLS CUI [1])
Informed Consent parent | Informed Consent Guardian
Item
written informed consent obtained from the parent or guardian of the subject.
boolean
C0021430 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1274041 (UMLS CUI [2,2])
Disease Free of | examination; clinical
Item
free of obvious health problems as established by medical history and clinical examination before entering into the study.
boolean
C0012634 (UMLS CUI [1,1])
C0332296 (UMLS CUI [1,2])
C1456356 (UMLS CUI [2])
Hepatitis B vaccination Dosage Quantity
Item
subjects should have received two doses of hepatitis b vaccine: at birth and at approximately one month of age.
boolean
C0474232 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Immunosuppressive Agents Administration chronic | Biological Response Modifiers
Item
chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs during the study period.
boolean
C0021081 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0005525 (UMLS CUI [2])
Vaccine Illicit Study Protocol
Item
planned administration/ administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of the vaccine and ending 30 days after.
boolean
C0042210 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Immunosuppression | Immunologic Deficiency Syndromes | HIV Infections
Item
any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (hiv) infection.
boolean
C4048329 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Immunodeficiency congenital Family history | Immunodeficiency Hereditary Family history
Item
a family history of congenital or hereditary immunodeficiency.
boolean
C0853602 (UMLS CUI [1,1])
C0241889 (UMLS CUI [1,2])
C0021051 (UMLS CUI [2,1])
C0439660 (UMLS CUI [2,2])
C0241889 (UMLS CUI [2,3])
History of allergies | history of allergic reaction | Exacerbation Probably Due to Vaccine Component
Item
history of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
boolean
C0489531 (UMLS CUI [1])
C2106654 (UMLS CUI [2])
C0235874 (UMLS CUI [3,1])
C0750492 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0042210 (UMLS CUI [3,4])
C1705248 (UMLS CUI [3,5])
Congenital Abnormality Major | Chronic disease Serious
Item
major congenital defects or serious chronic illness.
boolean
C0000768 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0008679 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
nervous system disorder | Seizures
Item
history of any neurologic disorders or seizures.
boolean
C0027765 (UMLS CUI [1])
C0036572 (UMLS CUI [2])
Acute Disease
Item
acute disease at the time of enrolment.
boolean
C0001314 (UMLS CUI [1])
Immunoglobulins | Blood product | Immunoglobulins Administration Planned | Blood product Administration Planned
Item
administration of immunoglobulins and/or any blood products since birth or planned administration during the study period.
boolean
C0021027 (UMLS CUI [1])
C0456388 (UMLS CUI [2])
C0021027 (UMLS CUI [3,1])
C1533734 (UMLS CUI [3,2])
C1301732 (UMLS CUI [3,3])
C0456388 (UMLS CUI [4,1])
C1533734 (UMLS CUI [4,2])
C1301732 (UMLS CUI [4,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial